News & Updates
Filter by Specialty:
COVID-19 vaccines safe for patients with rheumatic, musculoskeletal disease
Vaccines against SARS-CoV-2 has a safety profile that is similar in patients with inflammatory/autoimmune rheumatic and musculoskeletal disease (I-RMD) and those with noninflammatory RMD (NI-RMD), according to a study. The vaccines are well tolerated with rare reports of I-RMD flare and serious adverse events.
COVID-19 vaccines safe for patients with rheumatic, musculoskeletal disease
11 Jan 2022
Pyrotinib + capecitabine extends OS in metastatic breast cancer
Patients with previously treated HER2-positive metastatic breast cancer (mBC) experienced a 31 percent reduced risk of death when treated with pyrotinib plus capecitabine than lapatinib plus capecitabine, according to updated results of the phase III PHOEBE trial from China.
Pyrotinib + capecitabine extends OS in metastatic breast cancer
10 Jan 2022
5α-reductase inhibitors help reduce SARS-CoV-2 infection risk in men
Use of 5α-reductase inhibitors (5ARIs) appears to lower the risk of community-acquired infection with SARS-CoV-2 in men without prostate cancer, according to a study, noting that treatment with this drug class can help ease the burden of COVID-19.
5α-reductase inhibitors help reduce SARS-CoV-2 infection risk in men
10 Jan 2022
Lower rates of digestive cancer treatment in older patients due to pandemic lockdowns
The coronavirus disease 2019 (COVID-19) pandemic has led to a sharp decline in treatment for older patients with newly diagnosed cancers of the digestive system, a recent study has found.
